Evidence map›Paper›PMID 35530025›Full record

ArticleFrontiers in psychiatry2022

Effect of

Micaela Tirri, Sabrine Bilel, Raffaella Arfè, Giorgia Corli, Beatrice Marchetti, Tatiana Bernardi, Federica Boccuto, Giovanni Serpelloni, Francesco Botrè, Fabio De-Giorgio and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Molecular and Medical Aspects of Psychedelics.International journal of molecular sciences · 2023
    Review
  8. Behavioral and Pharmacokinetics Studies ofInternational journal of molecular sciences · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Micaela TirriSection of Legal Medicine and Laboratory for Advanced Therapy Technologies (LTTA) Centre, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Sabrine BilelSection of Legal Medicine and Laboratory for Advanced Therapy Technologies (LTTA) Centre, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Raffaella ArfèSection of Legal Medicine and Laboratory for Advanced Therapy Technologies (LTTA) Centre, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Giorgia CorliSection of Legal Medicine and Laboratory for Advanced Therapy Technologies (LTTA) Centre, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Beatrice MarchettiSection of Legal Medicine and Laboratory for Advanced Therapy Technologies (LTTA) Centre, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Tatiana BernardiDepartment of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Federica BoccutoDepartment of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Giovanni SerpelloniNeuroscience Clinical Center and Transcranial Magnetic Stimulation (TMS) Unit, Verona, Italy.
Francesco BotrèInstitute of Sport Science University of Lausanne (ISSUL), Lausanne, Switzerland.
Fabio De-GiorgioSection of Legal Medicine, Department of Health Care Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Rome, Italy.
Krystyna GolembiowskaDepartment of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Krakòw, Poland.
Matteo MartiSection of Legal Medicine and Laboratory for Advanced Therapy Technologies (LTTA) Centre, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
University of Ferrara · ITPolish Academy of Sciences · PLUniversità Cattolica del Sacro Cuore · ITUniversity of Lausanne · CHUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, the market for new psychoactive substances has been enriched by numerous psychedelic phenethylamines, which mimic the psychoactive effect of lysergic acid diethylamide (LSD). In particular, the -NBOMe series, which are more potent than their 2C compounds analogs, are considered worthy substitutes for LSD by users. The purpose of this study was to assess the effects of 25

Indexed as

2C compoundsDUID (driving under the influence of drugs)LSD-NBOMenovel psychoactive substances (NPS)phenethylaminepre-pulse inhibitionsensorimotor

Identifiers

PMID35530025
PMCPMC9069068
OpenAlexW4224301560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.